China NMPA Product Recall - Central workstation monitoring system; central workstation; telemetry monitoring system

On December 12, 2019, GE Healthcare Systems Trading Development (Shanghai) Co., Ltd. initiated a voluntary Class III recall of several medical devices, including central workstation monitoring systems, telemetry monitoring systems, and central workstations. This action, reported to the National Medical Products Administration (NMPA) and publicized by the Shanghai Municipal Drug Administration, was prompted by the discovery of potential network security vulnerabilities within certain versions of these central workstations and telemetry servers. The identified flaw poses a risk where unauthorized individuals could exploit special techniques to gain network access permissions. This unauthorized access could potentially lead to targeted network attacks, rendering the equipment unusable, or altering critical equipment settings and alarm limits. Such modifications could result in the loss of patient monitoring capabilities or the failure of alarm systems, posing significant safety concerns. Detailed information regarding the specific affected product models, specifications, and batches is available in an accompanying "Medical Device Recall Event Report Form." This proactive measure by GE Healthcare underscores the company's commitment to patient safety and product integrity under the NMPA's regulatory framework.